Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
ES11 - Lung Cancer Plasticity and Drug Resistance
- 15:15 - 16:45
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Educational Session
- Track: Biology
- Moderators:Luca Roz, Nagahiro Saijo
-
+
ES11.05 - MSK-IMPACT, a Hospital Based Genetic Screening Using FDA-Approved NGS System
15:55 - 16:05 | Presenter: Alexander Drilon
- Abstract
Loading...
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.07 - Activity of Larotrectinib in TRK Fusion Lung Cancer
15:55 - 16:00 | Presenter: Anna F Farago | Author(s): Shivaani Kummar, Victor Moreno, Jyoti D Patel, Ulrik Lassen, Lee Rosen, Nora C. Ku, Michael C. Cox, Shivani Nanda, Barrett H. Childs, David M. Hyman, Alexander Drilon
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-122 - A Clinical Utility Study of Plasma DNA Next Generation Sequencing Guided Treatment of Uncommon Drivers in Advanced Non-Small-Cell Lung Cancers
09:45 - 09:45 | Presenter: Hai-yan Tu | Author(s): Chong-Rui Xu, Candace Tong-Li, Michael Offin, Pedram Razavi, Emily Schapira, Azadeh Namakydoust, Adrian Lee, Nick Pavlakis, Stephen Clarke, Connie I Diakos, David Chan, Makenzie L Myers, Alex Makhnin, Harsh Jain, Andres Martinez, Zishan Iqbal, Ariana Adamski, Henry Li, Jennifer Hernandez, Sara Watford, Ali Hosseini, Tristan Shaffer, Lee Lim, Mark Li, Alexander Drilon, Marc Ladanyi, Maria E. Arcila, Valerie W. Rusch, David R Jones, Charles M Rudin, Andreas Rimner, James M Isbell, Bob T Li
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-39 - Molecular Characteristics, Immunophenotype, and Immune Checkpoint Inhibitor Response in BRAF Non-V600 Mutant Lung Cancers
09:45 - 09:45 | Presenter: Michael Offin | Author(s): Terry Pak, Sebastian Mondaca, Joseph Montecalvo, Natasha Rekhtman, Darragh F Halpenny, Stephanie L Wu, Mark G Kris, Paul Paik, Gregory J Riely, Charles M Rudin, David M. Hyman, Matthew Hellmann, Alexander Drilon, Josiah D Land, Larry Buie, Piro Lito, Rona Yaeger, Dazhi Liu, Bob T Li
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-12 - A Novel Activating MAP2K1 In-Frame Deletion Mediates Acquired Resistance to ROS1 TKIs in a Patient with ROS1 Fusion-Positive NSCLC
09:45 - 09:45 | Presenter: Hiroki Sato | Author(s): Adam J Schoenfeld, Evan Siau, Ken Suzawa, Christine Yue, Michael Offin, Alexander Drilon, Monika A Davare, Gregory J Riely, Marc Ladanyi, Romel Somwar
- Abstract
Loading... -
+
P1.14-25 - Targeting NRG1-Fusions in Lung Adenocarcinoma: Afatinib as a Novel Potential Treatment Strategy
09:45 - 09:45 | Presenter: Michael Duruisseaux | Author(s): Janessa J. Laskin, Khaled Tolba, Eva Brandén, Yasushi Goto, Robert C. Doebele, Parneet Kaur Cheema, Jacques Cadranel, Martin R. Jones, Alexander Drilon, Domenico Trombetta, Lucia A. Muscarella, Agnieszka Cseh, Flavio Solca, Stephen V. Liu
- Abstract
Loading... -
+
P1.14-50 - A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Robin Guo | Author(s): Isabel Preeshagul, Adam J Schoenfeld, Caroline G. McCarthy, Alex Makhnin, Andrew J. Plodkowski, Michelle S. Ginsberg, Monika A Davare, Lukas Delasos, Romel Somwar, Maria E. Arcila, Gregory J Riely, Natasha Rekhtman, Marc Ladanyi, Mark G Kris, Alexander Drilon
- Abstract
Loading...
-
+
PL02 - Presidential Symposium including Top 7 Rated Abstracts
- 08:00 - 10:15
- 9/09/2019
- Location: Barcelona (2005)
- IASLC CME Accredited
- Type: Plenary Session
- Track:
- Moderators:Giorgio Vittorio Scagliotti, Ramon Rami-Porta
-
+
PL02.08 - Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
09:10 - 09:20 | Presenter: Alexander Drilon | Author(s): Geoffrey R Oxnard, Lori Wirth, Benjamin Besse, Oliver Gautschi, Shao Weng Daniel Tan, Herbert H. Loong, Todd Bauer, Yu Jung Kim, Atsushi Horiike, Keunchil Park, Manisha Shah, Caroline McCoach, Lyudmila Bazhenova, Takashi Seto, Marcia Brose, Nathan Pennell, Jared Weiss, Ignacio Matos, Nir Peled, Byoung Chul Cho, Yuichiro Ohe, Karen L Reckamp, Valentina Boni, Miyako Satouchi, Gerald S Falchook, Wallace Akerley, Haruko Daga, Tomohiro Sakamoto, Jyoti D Patel, Nehal Lakhani, Fabrice Barlesi, Mark Burkard, Viola W. Zhu, Victor Moreno, Jacques Medioni, Marc Matrana, Christian Rolfo, Dae Ho Lee, Hovav Nechushtan, Melissa Johnson, Vamsidhar Velcheti, Makoto Nishio, Ryo Toyozawa, Kadoaki Ohashi, Lucy Song, Ji-Youn Han, Alexander Spira, Filippo Guglielmo Maria De Braud, Kristoffer Staal Rohrberg, Shinji Takeuchi, Jun Sakakibara-Konishi, Saiama Waqar, Hirotsugu Kenmotsu, Frederick Wilson, Binoj Nair, Elizabeth Olek, Jennifer Kherani, Kevin Ebata, Edward Zhu, Michele Nguyen, Luxi Yang, Xin Huang, Scott Cruickshank, Stephen Michael Rothenberg, Benjamin J Solomon, Koichi Goto, Vivek Subbiah
- Abstract
Loading...
-
+
PR03 - Press Conference
- 10:15 - 11:00
- 9/09/2019
- Location: CC7.1 A&B
- Type: Press Conference
- Track:
-
+
PR03.06 - Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
10:44 - 10:50
- Abstract
No abstract available for this presentation
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.02 - Entrectinib in Patients with ROS1-Positive NSCLC or NTRK Fusion-Positive Solid Tumors with CNS Metastases
15:50 - 15:55 | Presenter: Luis Paz-Ares | Author(s): Rafal Dziadziuszko, Alexander Drilon, Tom John, Matthew G Krebs, George Demetri, Alice T. Shaw, Salvatore Siena, Juergen Wolf, Anna F Farago, Brian Simmons, Chenglin Ye, Xinhui Huang, Robert C. Doebele
- Abstract
Loading...
-
+
P2.12 - Small Cell Lung Cancer/NET
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P2.12-13 - Lurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials
10:15 - 10:15 | Presenter: Santiago Ponce | Author(s): Emiliano Calvo, Maria Jose De Miguel, Cristiana Sessa, Maria Jose Flor, Alexander Drilon, Alejandro Falcon, Inmaculada Sanchez Simon, Rafael Nuñez, Xarles Erik Luepke, Nazly Cuevas-Melendez, Jose Antonio López-Vilariño, Salvador Fudio, Mariano Siguero, Martin Cullell-Young, Carmen Kahatt, Ali Zeaiter, Luis Paz-Ares
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.01 - Generation and Characterization of Novel Preclinical Disease Models of NSCLC with NRG1 Rearrangements to Improve Therapy
14:30 - 14:35 | Presenter: Eric Gladstone | Author(s): Morana Vojnic, Michael Offin, Lukas Delasos, Allan J. W. Lui, Evan Siau, Hirko Sato, Ryma Benayed, Renate Kurth, Marissa Mattar, Inna Khodos, Elisa De Stanchina, Robert Daly, Alison Schram, Alexander Drilon, Marc Ladanyi, Romel Somwar
- Abstract
Loading...